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Plasma samples from 1183 patients unoergoing primary liver transplantation were 
tested for anti-HCV by two methods: lrtho~ Hev ELISA Test System (lnA) and Chiron~ 
" ~ 1, . _ .• -I' c 
RlBATil HCV Test System (RIBA m. EIA results, O'or +, were recorded first followed by 
RlBA results, N = 'negative, P = positive, or 11 .... indetermmate. 'Concordant results - ON, 
+ P, +1 - were 'found in 1075 (91 %), discordaniresultS in 108 E9%F~ p' = <0.0005. Band 
.' 
patterns were described by stating the band position (1, 2', 3; or '4) and 'inserting a dash 
(-) if no band was visualized. Of + P samples, 47% showed all four bands, pattern = 
1234, and 15% the two band pattern -34. When the EIA was negative, OP, a reverse was 
seen: 8% showed 1234 and 81 % --34. There were 226 pa~ples which formed bands (+ p 
144, OP 36, +115, 0131). The frequency of bands was 4 = 32%, 3 = 31 %, 2 = 19%, and 
1 = 18%. Band 2 and the EIA test detect antibodies to the same c100-3 fragment and 
showed 76% concordance, p' = ' < 0.05. No eXpianation' is apparent for the lower 
concordance rate here than that between the EIA test and bands 3 = 96% or 4 = 88%. 
The EIA and RIBA II tests together with liver function tests and tissue pathology provide 
a basis for the Caiegori~fDdiagiiopip: ofeep~titis C. 
Key words: Hepatitis C, Hepatitis NANB, anti HeV, RIBA IT band patterns. 
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This study was designed to compare the results ofElA (c100-3 antigen) andFr~I~ IT (four HCV . 
'. '. " ,-, " •. , "" ,0-",'.' '" .'.,i-'l;"'...... ..,. r '..11." ; " ' .• ' 
antigens) tests for antibodies to recombinant fragmentsoE~e hepatitis.GW',us genome (HCV)./; 
", '".. .... ' .. ..,.J.. .. , ~I~4K _', "D~ ,,' 11-:", ....... • '\.. ID~I" :.." - ",,;',1< 1- '" ~D • .,., 
The antigens used in these tests were developed by E~hiron ~~~fClI~~!lf~: ~4 ~e test ~~e 
distributed by Ortho a~agnosticsI Inc. Because the EIA test .has beenK~pproved by the FDA we 
" " '. .... -..., .• ' "', '-."'._,,"'/ _. '" ' .. ' ;l t·, - -, .' ,) '" 
used it to declare a sample anti HCV + or O. The new test herein called RIBA IT is Chiron~ 
. .' '" '" " '-'. '·i·, '( t' 
RIBATM second generation assay utilizing five recombinant antigens, ~c1pIKding clOO-3. Other 
<. -, ~K:Kc~- " II~ . ....r. : 
antigens are 5-1-1 c33c, c22-3, and SOD. This second generation test is not FDA approved and 
• '.' , .;,..¥' _';. -, • I:;~ ~ D~KI ,,.t. \ 1 - ""'_ . , • , 
can be used only for research. Thus, results cannot be linked to patient identities, used for 
i. ' ,,"',_.,' > 
diagnosis or reported to primary care-givers. 
EIA and RIBA IT tests were done on a group of 1183 "high risk" patient samples residual 
", D~k . . 
from coagulation studies. These patients were considered K"hi~ risk" for,anti HCV because many' 
, :_' ., ,'" - • ~I .. "" ",,' t .. 
had received multiple transfusions before blood donations were routinely tested for anti-HCV 
, I~IID i. \ • 
(May 1990). All patients had life threatening, liver disease. Infection with HCV, if it had 
• I~III-~:IIKt- .l:,J.... " _i 
occurred, may have been primary or coinciden~K 
'. ~: 
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MATERIALS AND MEmODS 
The plasma samples were left-over from"Coagulation studies and had been stored at 
-70DC for,periods up to 8 years. Usually they were baseline samples from primary liver 
transplants but if thesewer~ exhausted the ~ndsaffIlple taken just before the anhepatic phase 
of the operation was used. This research was. C()nsidered exempt from the need for written 
consentand was approved by the University of Pittsburgh's Institutional Review Board.':;'; 
The EIA test for anti HCV was "Hepatitis C virus Encoded Antigen (Recombinant 
clOO(3) OrthoQlj HeV EUSA Test System." _ Tile manufacturer's 'suggested procedure was 
followed exactly. Initially reactive specimens were retested in duplicate and considered positive 
if either or both duplicates were greater than the cut off value. EIA results were reported as + 
or O. 
The RIBA II test was "ChironQlj RIBNlI HCV Test System Second Generation Assay. " 
Ortho Diagnostic Systems, Inc. distributes th~ test kits. We are grateful for their advice and 
provision of some of the kits used. The manufacturer's suggested procedures were followed. 
Results were reported as P (positive) if two or more bands were found, I (indeterminate) if only 
one band,resulted, .. andN ,(negative) if no, band Jonpe4. In.:the fmal analysis of band patterns 
intensities of ± (less than control!) were considered negative. Otherwise band intensities were 
, . 
. 
not used. Band patterns were describ~Iby the location of stained bands (position 1,2,3 or 4). 
qhere~eno ~eaction~ to the non-ymut>andS9D, human superoxide dismutase. This material 
is derived from. tlle;recombinant PNA. technology u~ to produce antigens clOO-3 and c22,.3 in 
iYC2St., ~t:is~nclud¢Kon the cellulo~ stripKt~DI4etect an'antibody to this possiblecontaminant.-. 
') 
j 
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RESULTS 
. 1 ~ 
Concordance Rate 
HCV markers are reported with the EIA . (E) results' first, 0 or +, and the RIBA n (R) 
results second, N, P, or I. Hence ON indicates negative and +P positive in both tests. 
Table 1 shows the cOncordant and discordant results. If the indeterminate readings in which only 
one band was visualized are included with the Ps, 91 % are matches - ON or + PI! - and the 
concordance rate between the two tests is highly significant at p<O.OOO5. " 
Ikmd Patterns in RIBA P or I Samples 
By definition RIBA positive (P) samples produce 2 to 4 visible antibody bands to the 
HCV fragments and indeterminate (I) samples respond with one band. The observed band 
positions are shown in Table 2. There are 11 possible positive patterns: 
4 antibodies - one pattern = 1234 
3 antibodies - four patterns = -234, 1-34, 124, 1OP~ 
2 antibodies - six patterns = 12--, 1-3-, 1-4, -23-, -24, and --34 
Indeterminate results show only one band, thus only four patterns are possible, 1 or 2 or 3 or 4. 
Table 2 shows that when EIA and RIBA n were both positive (+ P) pattern 1234 was 
most frequ~nt appearing in 47% of patient samples. The two band pattern --34 was next most 
. . . 
frequent, found in 16%. When the EIA test was m~gative (OP) almost the reverse was found. 
Pattern 1234 appeared in only 8% and the pattern --34 occurred in 81% of patient samples. 
This is illustrated in Figure 1. 
1 
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Band Frequency 
In all RIBA n positive ( + P, OP) and indeternlinate (+1, 01) samples band 4 occurred 194 
times (32%), band 3 187 times (31 %) band 2112 tithes:(19%) and band'1 107 times (18%). 
Band 2 and EIA Test Concordance 
The EIA test usesthe clOO-3 antigen as does the RIBA n test's band 2, thus concordance 
between EIA positivity and band 2 visualization is expected.· Table 3 shows that concordance 
occurred in 163 samples (76%). This was significant at p = <0.05. 
ER Categories in Various liver Disorders 
Table 4 lists the numbers of patients falling into each liver diagnosis and the number and 
percent within each diagnosis with the different ER categories. The discordant result + N was 
found most frequently in Autoimmune Hepatitis (12%), Chronic Hepatitis N (11 %) and Acute 
Hepatitis (10%). OPII occurred most commonly in NANB Hepatitis, (15%) and Autoimmune 
Hepatitis (12%). 
; ,,: 
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DISCUSSION 
The studies of Alter and his associates3 suggest that hepatitis C is the major if not the only 
cause of non-A non-B (NANB) hepatitis. Thus it is desirable to have an accurate test which 
detects an immunologic response to the virus early in the course of the disease. The 
concordance or agreement between the two tests used in our studies is great and highly 
significant. The discordant values are either + N or OP!I. The ER pattern + N is thought to be 
a "false" positive perhaps due to hypergammaglobulinemia. It is also possible to assume that it 
is an early manifestation of Rev in which the antibody has insufficient affinity to visualize the 
band. On the other hand, the discordant OP!I may represent a stage in the development of a full 
positive test and might be expected to be found in the window between RCV exposure and EIA 
positivity. Our studies do not offer evidence to support this premise. Date of exposure to the 
virus is unknown and serial pre-operative samples are unavailable. 
At this time we can only suggest that all blood donors and patients suspected of RCV 
infection be tested with an approved test. Those which are positive, especially those with 
abnormal liver function tests should have additional blood samples stored for future assays. The 
RIBA II test will be confirmatory but also, through the band patterns, may offer additional 
information about the stage of the immunological response. 
Much further study will be required to distinguish which 
patients of those with HCV antibodies are potentially infectious 
, I 
and which are immune. Although HCV positive patients presently 
are disqualified as blood donors, it remains to be determined if 
this policy is warranted for cadaveric organ donors with a 
previous history of good health, normal liver function tests, and 
an unlimited availability of liver and other tissues for direct 
histopathologic examination. 
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TABLE 1. ER (EIA-RIBA In OF BASELINE PLASMA SAMPLES FROM 
1183 PATIENTS UNDERGOING PRIMARY LIVER TRANSPLANT 
ER 
ON 
+p 
+I 
Concordant 
Number 
916 
144 
15 
ER 
+N 
OP 
01 
Discordant 
Number 
41 
36 
31 
TOTAL 1075 (91 %) 108 (9%) 
, I 
/ 
~Bib 2. RillA IT BAND PATTERNS IN EIA POSITIVE AND NEGATIVE PLASMA SAMPLES 
(BAATD 1:::5-1-1; BAND 2:::CI00-3; BAND 3=C33C; BAND 4:::C22-3) 
Bands Present in RIBA. Positive Samples 
ElA RIBA TOTAL 1234 -234 1-34 12-4 123- 12- 1-3- 1--4 -23- -2-4 --34 
+ p 144 68 19 13 1 12 2 2 2 2 1 22 
% 47 13 9 1 8 1 1 1 1 1 15 
o p 36 3 2 1 o o o o 1 o o 29 
% 8 6 3 3 81 
Bands Present in RIBA. Indetenninale Samples 
ElA RlBA TOTAL 1 2 3 4 
+ 15 1 4 9 
% 6 6 27 60 
o I 31 o 1 9 21 
% o 3 29 68 
, I 
TABLE 3. EIA POSITIVITY COMPARED TO BAND 2 VISUALIZATION IN 
180 RIBA II POSITIVE SAMPLES 
EIA Band 2 
+ + 
o o 
, i 
Concordant 
No. 
105 
31 
136 (76%) 
EIA 
+ 
o 
Discordant 
Band 2 
o 
+ 
No. 
39 
4 
44 (24%) 
/ 
TABLE 4. ER (EIA/RIBA m CATEGORIES IN PATIENTS LISTED BY 
FREQUENCY OF PATHOLOGICAL DIAGNOSES 
Liver Diagnosis Number of Number and (%) in each ER Category 
Patients ON +P +1 +N OP 
CC Cryptogenic Cirrhosis 205 149(73) 35(17) 3(1) 5(2) 8(4) 
PBC Primary Biliary Cirrhosis 178 167(94) 4(2) 0(0) 5(3) 0(0) 
PSC Sclerosing Cholangitis 113 101(89) 6(5) 1(1) 2(2) 2(2) 
MA Malignancy 110 93(85) 10(9) 1(1) 0(0) 4(4) 
ALC Alcoholic Cirrhosis 103 84(82) 10(10) 1(1) 2(2) 2(2) 
CU Cirrhosis - Uncertain Dx 102 74(73) 15(15) 0(0) 4(4) 2(2) 
CHB Chronic Hepatitis B 95 61(64) 14(15) 4(4) 10(11) 11(3) 
NANB Chronic NANB Hepatitis 86 34(40) 35(41) 2(2) 2(2) 9(10) 
AcHep Acute Hepatitis 49 38(78) 2(4) 2(4) 5(10) 1(2) 
a1ATD a 1 Antitrypsin Deficiency 29 23 (79) 5(17) 0(0) 1(3) 0(0) 
B-C Budd-Chiari 20 19(95) 1(5) 0(0) 0(0) 0(0) 
AuH Autoimmune Hepatitis 17 11(65) 2(12) 0(0) 2(12) 2(12) 
WD Wilson's Disease 16 14(88) 1(6) 0(0) 1(6) 0(0) 
MISC Miscellaneous . 60 51(85) 4(7) 1(2) 2(3) 0(0) 
TOTAL 1183 919(78) 144(12) 15(1) 41(3) 33(3) 
OI 
5(2) 
2(2) 
1(1) 
2(2) 
4(4) 
7(7) 
3(3) 
4(5) 
1(2) 
0(0) 
0(0) 
0(0) 
0(0) 
2(3) 
31(3) 
• The miscellaneous group 0[60 included: Secondary Biliary Cirrhosis (14), Hemochromatosis (9), Pediatric cirrhosis (6), Caroli's Disease (6), Submassive Hepatic 
Necrosis (4), Hemangioma (4), Biliary Atresia (3), Congenital Hepatic Fibrosis (3), Intra-Hepatic Veno-Occlusive Disease (3), Cystic Fibrosis (2), Trauma to Liver 
(2), Chronic Hepatitis (non-viral) (1), Byler's Disease (I), Polycystic Liver Disease (1), and Poisoning (I). 
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